Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.

Signify Premium Insight: Reimbursement Raises Prospects for Cardiac Plaque AI

Signify Premium Insights Subscription Required

19th October 2022 – Cleery has recently joined the group of AI vendors whose solutions qualify for reimbursement. In doing so AI progresses towards overcoming one of its biggest barriers; demonstrating a clear return on investment.

Signify Premium Insight: SOC Telemed Joins Telehealth Top Table

Signify Premium Insights Subscription Required

18th October 2022 – Last month, US telehealth vendor SOC Telemed acquired virtual behavioural health firm Forefront Telecare. In this insight we discuss this recent acquisition and what it means for the market.

Outpatient Imaging and Teleradiology Changing the Market Dynamic in the US

17th October 2022 – The US healthcare market is witnessing a dynamic shift in how and where patients want to receive care, with a greater utilisation of outpatient imaging and teleradiology services. In this insight, Signify Research Analysts’ evaluate what these market changes mean for vendors and the opportunities it creates.

Signify Premium Insight: Futures for the Faithful – Vendor Sentiment Index Q3

Signify Premium Insights Subscription Required

13th October 2022 – There are many challenges ahead for vendors looking to capitalise on the evolving medical imaging AI market, however, as shown in Signify Research’s Vendor Sentiment Index, there are also reasons for confidence.

Signify Premium Insight: Neusoft Medical to Float on United Imaging’s Rising Tide

Signify Premium Insights Subscription Required

11th October 2022 – Neusoft has announced that after three unsuccessful attempts, it is yet again planning to list publicly. Does it offer a unique proposition, or is the vendor just clinging on to its rivals’ coattails? This Insight explores its opportunity